Feb 2, 2025 | False Claims Act, federal investigations, Fraud Investigations, Government Investigations
On February 1, 2025, President Trump announced the imposition of substantial tariffs on goods imported from Canada, Mexico, and China. These tariffs are likely to come with an increase in customs enforcement, with customs officials ensuring that incoming goods are...
Jan 22, 2025 | False Claims Act
A nationwide civil complaint has been filed against Walgreens Boots Alliance, Walgreen Co. and various subsidiaries (“Walgreens”) in the U.S. District Court for the Northern District of Illinois. The 300-page complaint allege, inter alia, that the pharmacy giant...
Jan 17, 2025 | False Claims Act
Judge Saris of the U.S. District Court for the District of Massachusetts granted summary judgment in favor of the defendants in a qui tam action, ruling that the “but-for” causation standard should be applied when violations of the Anti-Kickback Statute (AKS) form the...
Jan 16, 2025 | False Claims Act
On January 15, 2025, the DOJ announced that its False Claims Act (FCA) recovery for fiscal year 2024 (which ended on September 30, 2024) exceeded $2.9 billion. This figure is slightly higher than the total recovery from the prior fiscal year ($2.7B) and the year...
Jan 14, 2025 | Administrative Law, False Claims Act, Fraud Investigations, Health Care, Health Care Fraud
Late last year, President Biden signed the annual National Defense Authorization Act (NDAA) for fiscal year 2025. This alone is not newsworthy, as this has happened every year since the NDAA was introduced in 1961. Generally speaking, the NDAA governs Department of...
Jan 8, 2025 | False Claims Act, Fraud Investigations
Although False Claims Act cases involving federal grant fraud may not be as common as those involving healthcare fraud, the consequences of such cases can be just as significant. Recently, Athira Pharma, a Washington state-based biopharmaceutical company, agreed to...
